Ellevest, Inc. Nevro Corp Transaction History

Ellevest, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 04, 2023	BUY	$30.17 - $41.11 $211 - $287	7 Added 700.0%	8 $0
Q4 2022 Feb 03, 2023	SELL	$36.43 - $49.4 $582 - $790	-16 Reduced 94.12%	1 $0
Q3 2022 Nov 02, 2022	SELL	$40.66 - $53.03 $365 - $477	-9 Reduced 34.62%	17 $1,000
Q2 2022 Jul 18, 2022	BUY	$40.85 - $77.67 $285 - $543	7 Added 36.84%	26 $1,000
Q1 2022 Apr 19, 2022	BUY	$59.95 - $92.06 $779 - $1,196	13 Added 216.67%	19 $1,000
Q4 2021 Jan 24, 2022	SELL	$81.07 - $121.29 $729 - $1,091	-9 Reduced 60.0%	6 $0
Q3 2021 Oct 19, 2021	BUY	$101.99 - $166.36 $1,529 - $2,495	15 New	15 $2,000

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $116M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.